| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-05 |